MOUD

Background There is little research on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study examined the prevalence of lifetime trauma and explored differences based on...

Background: Limited research has been conducted on lifetime trauma exposure among individuals undergoing medication treatment for opioid use disorder (MOUD). A multisite study provided an opportunity to investigate the prevalence of...

There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifetime trauma and differences by gender, PTSD status, and chronic pain.

Abstract Importance Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist. Objective To evaluate an implementation intervention over 2 years to...

Discussion Despite guidelines recommending MOUD, approximately 1 in 5 adults with past-year OUD received any MOUD. Furthermore, some groups were substantially less likely to receive MOUD, in particular Black adults, women, those unemployed...